Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2005 | 07-2004 | 07-2003 | 07-2002 | 07-2001 | |
| Sales | 156 | 264 | 116 | 3,206 | 2,410 |
| Cost of Goods | 52 | 131 | 58 | 1,599 | 1,363 |
| Gross Profit | 104 | 133 | 58 | 1,608 | 1,047 |
| Operating Expenses | 3,167 | 2,890 | 3,705 | 4,204 | 3,023 |
| Operating Income | -3,011 | -2,626 | -3,590 | -1,998 | -1,613 |
| Interest Expense | 110 | 316 | 99 | 39 | 11 |
| Other Income | 109 | 121 | 24 | 8 | 32 |
| Pre-tax Income | -3,012 | -2,821 | -3,664 | -2,029 | -1,592 |
| Income Tax | -1,165 | -218 | N/A | N/A | N/A |
| Net Income Continuous | -1,847 | -2,603 | -3,664 | -2,029 | -1,577 |
| Net Income Discontinuous | 1,530 | 295 | 380 | -194 | -205 |
| Net Income | $-317 | $-2,308 | $-3,284 | $-2,223 | $-1,782 |
| EPS Basic Total Ops | -1.36 | -1.36 | -2.88 | -2.32 | -2.24 |
| EPS Basic Continuous Ops | -1.52 | -1.52 | -3.20 | -2.16 | -2.00 |
| EPS Basic Discontinuous Ops | 0.16 | 0.16 | 0.32 | -0.16 | -0.24 |
| EPS Diluted Total Ops | -1.36 | -1.36 | -2.88 | -2.32 | -2.24 |
| EPS Diluted Continuous Ops | -1.52 | -1.52 | -3.20 | -2.16 | -2.00 |
| EPS Diluted Discontinuous Ops | 0.16 | 0.16 | 0.32 | -0.16 | -0.24 |
| EBITDA(a) | $-2,743 | $-2,351 | $-3,327 | $-1,543 | $-1,323 |